Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
Century Therapeutics (NASDAQ: IPSC) announced that Chad Cowan, Ph.D., Chief Scientific Officer, will present at Chardan’s 9th Annual Genetic Medicines Conference on Tuesday, October 21, 2025 at 12:20 p.m. ET in New York.
A live webcast of the presentation will be available on Century’s Investors page at www.centurytx.com, and an archived replay will be accessible for at least 30 days after the event.
Century Therapeutics (NASDAQ: IPSC) ha annunciato che Chad Cowan, Ph.D., Chief Scientific Officer, interverrà al Chardan’s 9th Annual Genetic Medicines Conference il martedì 21 ottobre 2025 alle ore 12:20 p.m. ET a New York.
Una webcast in diretta della presentazione sarà disponibile sulla pagina Investitori di Century all'indirizzo www.centurytx.com, e una riproduzione archiviata sarà accessibile per almeno 30 giorni dopo l'evento.
Century Therapeutics (NASDAQ: IPSC) anunció que Chad Cowan, Ph.D., Director Científico, presentará en Chardan’s 9th Annual Genetic Medicines Conference el martes 21 de octubre de 2025 a las 12:20 p.m. ET en Nueva York.
Una transmisión en directo estará disponible en la página de Inversores de Century en www.centurytx.com, y una reproducción archivada estará accesible durante al menos 30 días después del evento.
Century Therapeutics (NASDAQ: IPSC)는 Chad Cowan 박사, 최고 과학 책임자(CSO)가 Chardan의 제9회 연례 유전자 의약품 컨퍼런스에 2025년 10월 21일 화요일 동부표준시 12:20 p.m. 뉴욕에서 발표할 것이라고 발표했습니다.
발표의 실시간 생중계는 Century의 투자자 페이지 www.centurytx.com에서 이용 가능하며, 이벤트 종료 후 최소 30일간 아카이브 재생을 이용할 수 있습니다.
Century Therapeutics (NASDAQ: IPSC) a annoncé que Chad Cowan, Ph.D., Directeur Scientifique, présentera lors de la 9e Conférence annuelle sur les médicaments génétiques de Chardan le mardi 21 octobre 2025 à 12:20 p.m. ET à New York.
Une diffusion en direct de la présentation sera disponible sur la page des investisseurs de Century à www.centurytx.com, et une relecture enregistrée sera accessible pendant au moins 30 jours après l’événement.
Century Therapeutics (NASDAQ: IPSC) gab bekannt, dass Chad Cowan, Ph.D., Chief Scientific Officer, auf der Chardan’s 9th Annual Genetic Medicines Conference am Dienstag, dem 21. Oktober 2025 um 12:20 Uhr ET in New York auftreten wird.
Eine Live-Webcast der Präsentation wird auf der Investorenseite von Century unter www.centurytx.com verfügbar sein, und eine Archiv-Wiederholung wird mindestens 30 Tage nach der Veranstaltung zugänglich sein.
Century Therapeutics (NASDAQ: IPSC) أعلنت أن تشاد كووان، دكتوراه، كبير مسؤولي العلوم، سيلقي كلمة في المؤتمر التاسع لعلوم الجينات السنوي من تشاردن في الثلاثاء 21 أكتوبر 2025 الساعة 12:20 ظهرًا بتوقيت شرق الولايات المتحدة في نيويورك.
سيكون هناك بث مباشر عبر الويب للجلسة متاحًا على صفحة المستثمرين الخاصة بـ Century على www.centurytx.com، كما سيكون إعادة تشغيل أرشيفية متاحًا لمدة 30 يومًا على الأقل بعد الحدث.
Century Therapeutics (NASDAQ: IPSC) 宣布，首席科学官 Chad Cowan 博士将于 Chardan 的第九届年度基因药物大会 上发表，时间为 2025年10月21日星期二，东部时间中午12:20，地点在纽约。
该演讲的 现场网络直播 可在 Century 的投资人页 www.centurytx.com 查阅，且 档案回放 将在活动结束后至少保留 30 天。
- None.
- None.
PHILADELPHIA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced that Chad Cowan, Ph.D., Chief Scientific Officer of Century Therapeutics, will present at Chardan’s 9th Annual Genetic Medicines Conference on Tuesday, October 21, 2025, at 12:20 p.m. ET in New York, NY.
A live webcast of the presentation will be available on the Investors page of Century’s website at www.centurytx.com. An archived replay will be available for at least 30 days.
About Century Therapeutics
Century Therapeutics (NASDAQ: IPSC) is a clinical-stage biotechnology company advancing a pipeline of induced pluripotent stem cell (iPSC)-derived cell therapies with the potential to meaningfully address autoimmune diseases and cancer. The company’s therapies are derived from its iPSC cell foundry and leverage its novel immune evasion engineering technology, Allo-Evasion™. Century believes its approach to developing off-the-shelf cell therapies will expand patient access and provide advantages over existing cell therapies which will ultimately advance the course of care. For more information on Century Therapeutics, please visit www.centurytx.com and connect with us on LinkedIn.
For More Information:
Century Therapeutics
Douglas Carr
Senior Vice President, Finance
investor.relations@centurytx.com
JPA Health
Sarah McCabe
smccabe@jpa.com
FAQ
When will Century Therapeutics (IPSC) present at Chardan’s 9th Annual Genetic Medicines Conference?
Who from Century Therapeutics will present at the October 21, 2025 Chardan conference?
How can investors watch the Century Therapeutics (IPSC) presentation on October 21, 2025?
Will Century Therapeutics’ (IPSC) presentation at Chardan be available after the event?
What topics will Century Therapeutics (IPSC) likely cover at the Chardan Genetic Medicines Conference on October 21, 2025?
